These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22216116)

  • 1. Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites.
    Menter DG; Ramsauer VP; Harirforoosh S; Chakraborty K; Yang P; Hsi L; Newman RA; Krishnan K
    PLoS One; 2011; 6(12):e28813. PubMed ID: 22216116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
    Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats.
    Hooiveld GJ; Vos TA; Scheffer GL; Van Goor H; Koning H; Bloks V; Loot AE; Meijer DK; Jansen PL; Kuipers F; Müller M
    Gastroenterology; 1999 Sep; 117(3):678-87. PubMed ID: 10464145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
    Sivaprasad U; Abbas T; Dutta A
    Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.
    Göbel A; Pählig S; Motz A; Breining D; Traikov S; Hofbauer LC; Rachner TD
    Biochem Biophys Res Commun; 2024 May; 710():149841. PubMed ID: 38588613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
    Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
    J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.
    Neuvonen PJ; Backman JT; Niemi M
    Clin Pharmacokinet; 2008; 47(7):463-74. PubMed ID: 18563955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of acetylcholine activated potassium current (I KACh) by simvastatin, not pravastatin in mouse atrial cardiomyocyte: possible atrial fibrillation preventing effects of statin.
    Cho KI; Cha TJ; Lee SJ; Shim IK; Zhang YH; Heo JH; Kim HS; Kim SJ; Kim KL; Lee JW
    PLoS One; 2014; 9(10):e106570. PubMed ID: 25329899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes.
    Ganesan S; Ito MK
    Metab Syndr Relat Disord; 2013 Aug; 11(4):251-5. PubMed ID: 23496027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.
    Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R
    Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins with different lipophilic indices exert distinct effects on skeletal, cardiac and vascular smooth muscle.
    Irwin JC; Fenning AS; Vella RK
    Life Sci; 2020 Feb; 242():117225. PubMed ID: 31881229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells.
    Dong W; Vuletic S; Albers JJ
    J Lipid Res; 2009 Oct; 50(10):2095-102. PubMed ID: 19461118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC.
    Bergman M; Salman H; Djaldetti M; Bessler H
    Vascul Pharmacol; 2011; 54(3-6):88-92. PubMed ID: 21440087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of acid-base imbalance in statin-induced myotoxicity.
    Taha DA; De Moor CH; Barrett DA; Lee JB; Gandhi RD; Hoo CW; Gershkovich P
    Transl Res; 2016 Aug; 174():140-160.e14. PubMed ID: 27083388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.
    Verhulst A; D'Haese PC; De Broe ME
    J Am Soc Nephrol; 2004 Sep; 15(9):2249-57. PubMed ID: 15339974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.
    Izidoro-Toledo TC; Guimaraes DA; Belo VA; Gerlach RF; Tanus-Santos JE
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):547-54. PubMed ID: 21448567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Simvastatin and Pravastatin on the Biophysical Properties of Model Lipid Bilayers and Plasma Membranes of Live Cells.
    Polita AR; Bagdonaitė RT; Shivabalan AP; Valinčius G
    ACS Biomater Sci Eng; 2024 Sep; 10(9):5714-5722. PubMed ID: 39180473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.